JPH0549647B2 - - Google Patents
Info
- Publication number
- JPH0549647B2 JPH0549647B2 JP57503548A JP50354882A JPH0549647B2 JP H0549647 B2 JPH0549647 B2 JP H0549647B2 JP 57503548 A JP57503548 A JP 57503548A JP 50354882 A JP50354882 A JP 50354882A JP H0549647 B2 JPH0549647 B2 JP H0549647B2
- Authority
- JP
- Japan
- Prior art keywords
- cells
- lattice
- collagen
- skin
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000008186 Collagen Human genes 0.000 abstract description 92
- 108010035532 Collagen Proteins 0.000 abstract description 92
- 229920001436 collagen Polymers 0.000 abstract description 92
- 238000000034 method Methods 0.000 abstract description 70
- 239000007900 aqueous suspension Substances 0.000 abstract description 13
- 229920002683 Glycosaminoglycan Polymers 0.000 abstract description 12
- 238000010899 nucleation Methods 0.000 abstract description 8
- 238000011160 research Methods 0.000 abstract description 8
- 230000008569 process Effects 0.000 abstract description 7
- 238000011084 recovery Methods 0.000 abstract description 7
- 230000002829 reductive effect Effects 0.000 abstract description 7
- 230000010388 wound contraction Effects 0.000 abstract description 6
- 238000009826 distribution Methods 0.000 abstract description 4
- 238000005507 spraying Methods 0.000 abstract description 4
- 230000003176 fibrotic effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 144
- 210000003491 skin Anatomy 0.000 description 71
- 208000027418 Wounds and injury Diseases 0.000 description 50
- 206010052428 Wound Diseases 0.000 description 49
- 239000012528 membrane Substances 0.000 description 49
- 210000001519 tissue Anatomy 0.000 description 34
- 239000003012 bilayer membrane Substances 0.000 description 24
- 229920001296 polysiloxane Polymers 0.000 description 23
- 210000002919 epithelial cell Anatomy 0.000 description 22
- 239000000725 suspension Substances 0.000 description 20
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- 210000002615 epidermis Anatomy 0.000 description 16
- 238000001356 surgical procedure Methods 0.000 description 16
- 239000000835 fiber Substances 0.000 description 15
- 210000000056 organ Anatomy 0.000 description 15
- 210000004207 dermis Anatomy 0.000 description 14
- 239000011148 porous material Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 210000000981 epithelium Anatomy 0.000 description 11
- 238000011081 inoculation Methods 0.000 description 11
- 239000000463 material Substances 0.000 description 11
- 230000037390 scarring Effects 0.000 description 11
- 210000004204 blood vessel Anatomy 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 238000011282 treatment Methods 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 230000008929 regeneration Effects 0.000 description 9
- 238000011069 regeneration method Methods 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 230000010261 cell growth Effects 0.000 description 8
- 230000006378 damage Effects 0.000 description 8
- 239000012530 fluid Substances 0.000 description 8
- 239000006260 foam Substances 0.000 description 8
- 208000015181 infectious disease Diseases 0.000 description 8
- 239000006285 cell suspension Substances 0.000 description 7
- 239000006185 dispersion Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 206010040844 Skin exfoliation Diseases 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 238000006065 biodegradation reaction Methods 0.000 description 6
- 230000012292 cell migration Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 210000003780 hair follicle Anatomy 0.000 description 6
- 238000003306 harvesting Methods 0.000 description 6
- 239000003018 immunosuppressive agent Substances 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 5
- 238000004132 cross linking Methods 0.000 description 5
- 238000007710 freezing Methods 0.000 description 5
- 230000008014 freezing Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 208000005156 Dehydration Diseases 0.000 description 4
- 206010051814 Eschar Diseases 0.000 description 4
- 102000004142 Trypsin Human genes 0.000 description 4
- 108090000631 Trypsin Proteins 0.000 description 4
- 210000000270 basal cell Anatomy 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 230000018044 dehydration Effects 0.000 description 4
- 238000006297 dehydration reaction Methods 0.000 description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
- 231100000333 eschar Toxicity 0.000 description 4
- 230000004907 flux Effects 0.000 description 4
- 210000004907 gland Anatomy 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 230000008595 infiltration Effects 0.000 description 4
- 238000001764 infiltration Methods 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 230000000877 morphologic effect Effects 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- 239000012588 trypsin Substances 0.000 description 4
- 229920001287 Chondroitin sulfate Polymers 0.000 description 3
- 102000029816 Collagenase Human genes 0.000 description 3
- 108060005980 Collagenase Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 206010072170 Skin wound Diseases 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 210000002808 connective tissue Anatomy 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 102000034240 fibrous proteins Human genes 0.000 description 3
- 108091005899 fibrous proteins Proteins 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- 229940124589 immunosuppressive drug Drugs 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000001788 irregular Effects 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 210000000106 sweat gland Anatomy 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- 229920000045 Dermatan sulfate Polymers 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 229920002971 Heparan sulfate Polymers 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229920000288 Keratan sulfate Polymers 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000000735 allogeneic effect Effects 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229940094517 chondroitin 4-sulfate Drugs 0.000 description 2
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 2
- 229960002424 collagenase Drugs 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 2
- 229940051593 dermatan sulfate Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003195 fascia Anatomy 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229960003444 immunosuppressant agent Drugs 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000012808 pre-inoculation Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000002271 resection Methods 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 239000013464 silicone adhesive Substances 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000000438 stratum basale Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000003104 tissue culture media Substances 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 206010006802 Burns second degree Diseases 0.000 description 1
- 206010006803 Burns third degree Diseases 0.000 description 1
- 208000018380 Chemical injury Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 241000255749 Coccinellidae Species 0.000 description 1
- 102000004726 Connectin Human genes 0.000 description 1
- 108010002947 Connectin Proteins 0.000 description 1
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010039580 Scar Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 239000002870 angiogenesis inducing agent Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 239000003855 balanced salt solution Substances 0.000 description 1
- 238000001266 bandaging Methods 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002729 catgut Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000009087 cell motility Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- ZCDOYSPFYFSLEW-UHFFFAOYSA-N chromate(2-) Chemical compound [O-][Cr]([O-])(=O)=O ZCDOYSPFYFSLEW-UHFFFAOYSA-N 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 230000008508 epithelial proliferation Effects 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 229940125721 immunosuppressive agent Drugs 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 210000004088 microvessel Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000004911 serous fluid Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000037974 severe injury Diseases 0.000 description 1
- 230000009528 severe injury Effects 0.000 description 1
- 229920000260 silastic Polymers 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 159000000000 sodium salts Chemical group 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000000498 stratum granulosum Anatomy 0.000 description 1
- 210000000439 stratum lucidum Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000025366 tissue development Effects 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000009966 trimming Methods 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 210000005167 vascular cell Anatomy 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037373 wrinkle formation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Prostheses (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Photovoltaic Devices (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US315233 | 1981-10-26 | ||
| US06/315,233 US4458678A (en) | 1981-10-26 | 1981-10-26 | Cell-seeding procedures involving fibrous lattices |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58501817A JPS58501817A (ja) | 1983-10-27 |
| JPH0549647B2 true JPH0549647B2 (enExample) | 1993-07-26 |
Family
ID=23223481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP82503548A Granted JPS58501817A (ja) | 1981-10-26 | 1982-10-26 | 細胞を接種した繊維格子 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4458678A (enExample) |
| EP (1) | EP0091952B1 (enExample) |
| JP (1) | JPS58501817A (enExample) |
| AT (1) | ATE20186T1 (enExample) |
| DE (1) | DE3271581D1 (enExample) |
| WO (1) | WO1983001384A1 (enExample) |
Families Citing this family (216)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4418691A (en) * | 1981-10-26 | 1983-12-06 | Massachusetts Institute Of Technology | Method of promoting the regeneration of tissue at a wound |
| US4894063A (en) * | 1983-05-24 | 1990-01-16 | Baxter International Inc. | Barrier layer for implantable tendons and ligaments |
| US4713055A (en) * | 1983-06-22 | 1987-12-15 | Viggiano Donato A | Artificially vascularized graft |
| EP0152431A4 (en) * | 1983-07-25 | 1986-11-27 | John C Medlen | MATERIAL FOR REGENERATING COLLAGEN LIGAMENTS AND TONES. |
| US4837285A (en) * | 1984-03-27 | 1989-06-06 | Medimatrix | Collagen matrix beads for soft tissue repair |
| CA1295796C (en) * | 1984-03-27 | 1992-02-18 | Conrad Whyne | Biodegradable matrix and methods for producing same |
| US4662884A (en) * | 1984-04-25 | 1987-05-05 | University Of Utah Research Foundation | Prostheses and methods for promoting nerve regeneration |
| US4778467A (en) * | 1984-04-25 | 1988-10-18 | The University Of Utah | Prostheses and methods for promoting nerve regeneration and for inhibiting the formation of neuromas |
| DE3521684A1 (de) * | 1985-06-18 | 1986-12-18 | Dr. Müller-Lierheim KG, Biologische Laboratorien, 8033 Planegg | Verfahren zur beschichtung von polymeren |
| US4983580A (en) * | 1986-04-04 | 1991-01-08 | Allergan, Inc. | Methods and materials for use in corneal wound healing |
| US4981841A (en) * | 1986-04-04 | 1991-01-01 | Allergan, Inc. | Methods and materials for use in corneal wound healing |
| US5863531A (en) * | 1986-04-18 | 1999-01-26 | Advanced Tissue Sciences, Inc. | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
| US5510254A (en) * | 1986-04-18 | 1996-04-23 | Advanced Tissue Sciences, Inc. | Three dimensional cell and tissue culture system |
| US4963489A (en) * | 1987-04-14 | 1990-10-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
| US5266480A (en) * | 1986-04-18 | 1993-11-30 | Advanced Tissue Sciences, Inc. | Three-dimensional skin culture system |
| US5160490A (en) * | 1986-04-18 | 1992-11-03 | Marrow-Tech Incorporated | Three-dimensional cell and tissue culture apparatus |
| US5032508A (en) * | 1988-09-08 | 1991-07-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
| US4760131A (en) * | 1986-04-23 | 1988-07-26 | Collagen Corporation | Wound-healing composition |
| CA1340581C (en) * | 1986-11-20 | 1999-06-08 | Joseph P. Vacanti | Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices |
| US5804178A (en) * | 1986-11-20 | 1998-09-08 | Massachusetts Institute Of Technology | Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue |
| US6309635B1 (en) | 1986-11-20 | 2001-10-30 | Children's Medical Center Corp. | Seeding parenchymal cells into compression resistant porous scaffold after vascularizing in vivo |
| FR2612939B1 (fr) * | 1987-03-26 | 1989-06-23 | Cird | Equivalent de peau |
| FR2612938B1 (fr) * | 1987-03-26 | 1989-06-23 | Cird | Procede d'obtention d'un equivalent de peau et equivalent de peau correspondant |
| WO1988008305A1 (en) * | 1987-04-28 | 1988-11-03 | The Regents Of The University Of California | Method and apparatus for preparing composite skin replacement |
| US5273900A (en) * | 1987-04-28 | 1993-12-28 | The Regents Of The University Of California | Method and apparatus for preparing composite skin replacement |
| US5681353A (en) * | 1987-07-20 | 1997-10-28 | Regen Biologics, Inc. | Meniscal augmentation device |
| US5158574A (en) * | 1987-07-20 | 1992-10-27 | Regen Corporation | Prosthetic meniscus |
| US5735902A (en) * | 1987-07-20 | 1998-04-07 | Regen Biologics, Inc. | Hand implant device |
| US5007934A (en) * | 1987-07-20 | 1991-04-16 | Regen Corporation | Prosthetic meniscus |
| US5108438A (en) * | 1989-03-02 | 1992-04-28 | Regen Corporation | Prosthetic intervertebral disc |
| US5116374A (en) * | 1989-03-02 | 1992-05-26 | Regen Corporation | Prosthetic meniscus |
| US4880429A (en) * | 1987-07-20 | 1989-11-14 | Stone Kevin R | Prosthetic meniscus |
| US5258043A (en) * | 1987-07-20 | 1993-11-02 | Regen Corporation | Method for making a prosthetic intervertebral disc |
| US5263984A (en) * | 1987-07-20 | 1993-11-23 | Regen Biologics, Inc. | Prosthetic ligaments |
| US5306311A (en) * | 1987-07-20 | 1994-04-26 | Regen Corporation | Prosthetic articular cartilage |
| US4947840A (en) * | 1987-08-21 | 1990-08-14 | Massachusetts Institute Of Technology | Biodegradable templates for the regeneration of tissues |
| US5015584A (en) * | 1987-10-14 | 1991-05-14 | Board Of Regents, The University Of Texas System | Epidermal graft system |
| DE3739247C2 (de) * | 1987-11-19 | 1996-11-21 | Dade Int Inc | Blutungszeitmeßeinrichtung |
| IL90690A0 (en) * | 1988-09-30 | 1990-01-18 | Organogenesis Inc | Tissue equivalents and their preparation |
| US5521087A (en) * | 1989-05-10 | 1996-05-28 | Massachusetts Institute Of Technology | Method for producing oriented connective tissue cells in a ligament configuration |
| US4969903A (en) * | 1989-11-13 | 1990-11-13 | Wilfredo Valle | Hair implant system |
| ATE161408T1 (de) * | 1990-04-24 | 1998-01-15 | Mark Eisenberg | Zusammengesetztes äquivalent der lebenden haut |
| US5645591A (en) | 1990-05-29 | 1997-07-08 | Stryker Corporation | Synthetic bone matrix |
| DE4026153A1 (de) * | 1990-08-17 | 1992-02-20 | Sebapharma Gmbh & Co | Wundverband |
| DE4028088A1 (de) * | 1990-09-05 | 1992-04-16 | Berg Ernes Elme Dipl Ing | Resorbierbare kollagenimplantate |
| US8067149B2 (en) * | 1990-09-12 | 2011-11-29 | Lifecell Corporation | Acellular dermal matrix and method of use thereof for grafting |
| US5618531A (en) | 1990-10-19 | 1997-04-08 | New York University | Method for increasing the viability of cells which are administered to the brain or spinal cord |
| US5610753A (en) * | 1991-12-12 | 1997-03-11 | Eastman Kodak Company | Optical design of laser scanner to reduce thermal sensitivity |
| US6689608B1 (en) | 1993-02-01 | 2004-02-10 | Massachusetts Institute Of Technology | Porous biodegradable polymeric materials for cell transplantation |
| US5514378A (en) * | 1993-02-01 | 1996-05-07 | Massachusetts Institute Of Technology | Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures |
| US5916557A (en) * | 1993-11-12 | 1999-06-29 | The Trustees Of Columbia University In The City Of New York | Methods of repairing connective tissues |
| ES2163519T3 (es) * | 1994-06-30 | 2002-02-01 | Dade Behring Inc | Miembros separadores bioactivos porosos. |
| EP0717630A1 (de) * | 1994-07-08 | 1996-06-26 | SULZER Medizinaltechnik AG | Verfahren zur herstellung von implantationsmaterialien |
| US20020055786A1 (en) * | 1994-08-16 | 2002-05-09 | Anthony Atala | Reconstruction of urological structures with polymeric matrices |
| US6294202B1 (en) | 1994-10-06 | 2001-09-25 | Genzyme Corporation | Compositions containing polyanionic polysaccharides and hydrophobic bioabsorbable polymers |
| US5716404A (en) * | 1994-12-16 | 1998-02-10 | Massachusetts Institute Of Technology | Breast tissue engineering |
| US5713374A (en) * | 1995-02-10 | 1998-02-03 | The Hospital For Joint Diseases Orthopaedic Institute | Fixation method for the attachment of wound repair materials to cartilage defects |
| US6080194A (en) * | 1995-02-10 | 2000-06-27 | The Hospital For Joint Disease Orthopaedic Institute | Multi-stage collagen-based template or implant for use in the repair of cartilage lesions |
| US7008634B2 (en) * | 1995-03-03 | 2006-03-07 | Massachusetts Institute Of Technology | Cell growth substrates with tethered cell growth effector molecules |
| US5904716A (en) * | 1995-04-26 | 1999-05-18 | Gendler; El | Method for reconstituting cartilage tissue using demineralized bone and product thereof |
| US6123727A (en) * | 1995-05-01 | 2000-09-26 | Massachusetts Institute Of Technology | Tissue engineered tendons and ligaments |
| US5855610A (en) | 1995-05-19 | 1999-01-05 | Children's Medical Center Corporation | Engineering of strong, pliable tissues |
| US6129761A (en) * | 1995-06-07 | 2000-10-10 | Reprogenesis, Inc. | Injectable hydrogel compositions |
| US6528483B2 (en) | 1995-06-07 | 2003-03-04 | André Beaulieu | Method of producing concentrated non-buffered solutions of fibronectin |
| US7112320B1 (en) | 1995-06-07 | 2006-09-26 | Andre Beaulieu | Solid wound healing formulations containing fibronectin |
| US5958716A (en) * | 1996-06-06 | 1999-09-28 | Dade Behring Inc. | Blood factor assay |
| WO1998013076A1 (en) * | 1996-09-24 | 1998-04-02 | Brigham And Women's Hospital | Cultured cell-seeded fibrous lattice for tissue replacement |
| US6146847A (en) * | 1996-11-01 | 2000-11-14 | Genespan Corporation | Stabilized transient gene expression |
| US6221997B1 (en) | 1997-04-28 | 2001-04-24 | Kimberly Ann Woodhouse | Biodegradable polyurethanes |
| GB9708692D0 (en) * | 1997-04-30 | 1997-06-18 | Jahoda Colin A B | Dermal sheath tissue and/or cells derived therefrom in wound healing |
| US7419661B2 (en) | 1997-04-30 | 2008-09-02 | The Centre Of Excellence For Life Sciences Limited | Dermal sheath tissue in wound healing |
| GB9713330D0 (en) * | 1997-06-25 | 1997-08-27 | Bridport Gundry Plc | Surgical implant |
| US6471993B1 (en) | 1997-08-01 | 2002-10-29 | Massachusetts Institute Of Technology | Three-dimensional polymer matrices |
| US5925053A (en) | 1997-09-02 | 1999-07-20 | Children's Medical Center Corporation | Multi-lumen polymeric guidance channel, method for promoting nerve regeneration, and method of manufacturing a multi-lumen nerve guidance channel |
| AU747166B2 (en) * | 1997-10-31 | 2002-05-09 | Children's Medical Center Corporation | Bladder reconstruction |
| ATE328617T1 (de) | 1997-10-31 | 2006-06-15 | Childrens Medical Center | Penis-rekonstruktion |
| US6030374A (en) * | 1998-05-29 | 2000-02-29 | Mcdaniel; David H. | Ultrasound enhancement of percutaneous drug absorption |
| US6398753B2 (en) | 1998-04-03 | 2002-06-04 | Mcdaniel David H. | Ultrasound enhancement of percutaneous drug absorption |
| US7004933B2 (en) | 1998-05-29 | 2006-02-28 | Light Bioscience L.L.C. | Ultrasound enhancement of percutaneous drug absorption |
| US6933326B1 (en) | 1998-06-19 | 2005-08-23 | Lifecell Coporation | Particulate acellular tissue matrix |
| US7662409B2 (en) | 1998-09-25 | 2010-02-16 | Gel-Del Technologies, Inc. | Protein matrix materials, devices and methods of making and using thereof |
| US6663659B2 (en) | 2000-01-13 | 2003-12-16 | Mcdaniel David H. | Method and apparatus for the photomodulation of living cells |
| US6887260B1 (en) * | 1998-11-30 | 2005-05-03 | Light Bioscience, Llc | Method and apparatus for acne treatment |
| US20060212025A1 (en) * | 1998-11-30 | 2006-09-21 | Light Bioscience, Llc | Method and apparatus for acne treatment |
| US9192780B2 (en) | 1998-11-30 | 2015-11-24 | L'oreal | Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders |
| US6676655B2 (en) | 1998-11-30 | 2004-01-13 | Light Bioscience L.L.C. | Low intensity light therapy for the manipulation of fibroblast, and fibroblast-derived mammalian cells and collagen |
| US6936044B2 (en) * | 1998-11-30 | 2005-08-30 | Light Bioscience, Llc | Method and apparatus for the stimulation of hair growth |
| US6283956B1 (en) | 1998-11-30 | 2001-09-04 | David H. McDaniels | Reduction, elimination, or stimulation of hair growth |
| US6884427B1 (en) * | 1999-02-08 | 2005-04-26 | Aderans Research Institute, Inc. | Filamentary means for introducing agents into tissue of a living host |
| WO2000047129A2 (en) * | 1999-02-11 | 2000-08-17 | The General Hospital Corporation | Microfabricated membranes and matrices |
| US6372494B1 (en) | 1999-05-14 | 2002-04-16 | Advanced Tissue Sciences, Inc. | Methods of making conditioned cell culture medium compositions |
| US20040167634A1 (en) * | 1999-05-26 | 2004-08-26 | Anthony Atala | Prosthetic kidney and its use for treating kidney disease |
| US6964685B2 (en) * | 1999-06-22 | 2005-11-15 | The Brigham And Women's Hospital, Inc. | Biologic replacement for fibrin clot |
| US20040059416A1 (en) * | 1999-06-22 | 2004-03-25 | Murray Martha M. | Biologic replacement for fibrin clot |
| WO2000078370A1 (en) * | 1999-06-22 | 2000-12-28 | The Brigham And Women's Hospital, Inc. | Biologic replacement for fibrin clot for intra-articular use |
| WO2001039694A2 (en) * | 1999-12-03 | 2001-06-07 | University Of Leeds | Repair of damaged tissue |
| US6428802B1 (en) | 1999-12-29 | 2002-08-06 | Children's Medical Center Corp. | Preparing artificial organs by forming polylayers of different cell populations on a substrate |
| US6368859B1 (en) | 1999-12-29 | 2002-04-09 | Children's Medical Center Corporation | Methods and compositions for producing a fascial sling |
| US6479064B1 (en) | 1999-12-29 | 2002-11-12 | Children's Medical Center Corporation | Culturing different cell populations on a decellularized natural biostructure for organ reconstruction |
| US6376244B1 (en) * | 1999-12-29 | 2002-04-23 | Children's Medical Center Corporation | Methods and compositions for organ decellularization |
| EP1309361A1 (en) * | 2000-08-08 | 2003-05-14 | Bioamide, Inc. | Scaffolds for tissue engineered hair |
| PT1357922E (pt) * | 2001-02-07 | 2011-09-01 | Mccomb Foundation Inc | Técnica de preparação e uso de suspensão celular |
| AUPR298901A0 (en) * | 2001-02-07 | 2001-03-08 | McComb Foundation, Inc., The | Cell suspension preparation technique and device |
| US7137975B2 (en) * | 2001-02-13 | 2006-11-21 | Aciont, Inc. | Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent |
| WO2002063962A1 (en) | 2001-02-14 | 2002-08-22 | Hariri Robert J | Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells |
| US20030104386A1 (en) * | 2001-08-31 | 2003-06-05 | The Regents Of The University Of California | Methods for the specific detection of redox-active tags and the use thereof for capillary gel electrophoresis and DNA sequencing |
| US20030054331A1 (en) * | 2001-09-14 | 2003-03-20 | Stemsource, Inc. | Preservation of non embryonic cells from non hematopoietic tissues |
| US20050260179A1 (en) * | 2001-11-06 | 2005-11-24 | The General Hospital Corporation D/B/A Massachusetts General Hospital | Stem and progenitor cell capture for tissue regeneration |
| EP1446171A1 (en) * | 2001-11-16 | 2004-08-18 | Children's Medical Center Corporation | Augmentation of organ function |
| US8404229B2 (en) * | 2001-12-07 | 2013-03-26 | Cytori Therapeutics, Inc. | Methods of using adipose derived stem cells to treat acute tubular necrosis |
| US7585670B2 (en) | 2001-12-07 | 2009-09-08 | Cytori Therapeutics, Inc. | Automated methods for isolating and using clinically safe adipose derived regenerative cells |
| US7771716B2 (en) | 2001-12-07 | 2010-08-10 | Cytori Therapeutics, Inc. | Methods of using regenerative cells in the treatment of musculoskeletal disorders |
| US20050008626A1 (en) * | 2001-12-07 | 2005-01-13 | Fraser John K. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
| US20060204556A1 (en) * | 2001-12-07 | 2006-09-14 | Cytori Therapeutics, Inc. | Cell-loaded prostheses for regenerative intraluminal applications |
| US20050048035A1 (en) | 2001-12-07 | 2005-03-03 | Fraser John K. | Methods of using regenerative cells in the treatment of stroke and related diseases and disorders |
| US20050095228A1 (en) | 2001-12-07 | 2005-05-05 | Fraser John K. | Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
| US9597395B2 (en) | 2001-12-07 | 2017-03-21 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
| US7514075B2 (en) * | 2001-12-07 | 2009-04-07 | Cytori Therapeutics, Inc. | Systems and methods for separating and concentrating adipose derived stem cells from tissue |
| CA2849201A1 (en) | 2001-12-07 | 2003-07-03 | Macropore Biosurgery, Inc. | Adipose-derived cell processing unit |
| US7651684B2 (en) | 2001-12-07 | 2010-01-26 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
| US7595043B2 (en) * | 2001-12-07 | 2009-09-29 | Cytori Therapeutics, Inc. | Method for processing and using adipose-derived stem cells |
| EP1467746A4 (en) * | 2001-12-20 | 2006-10-04 | Macropore Inc | SYSTEMS AND METHODS FOR TREATING PATIENTS WITH COLLAGEN-RICH MATERIAL EXTRACTED FROM ADIPOSE TISSUES |
| US20040068284A1 (en) * | 2002-01-29 | 2004-04-08 | Barrows Thomas H. | Method for stimulating hair growth and kit for carrying out said method |
| US8394371B2 (en) | 2002-02-11 | 2013-03-12 | Neocutis Sa | Compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same |
| US20040131582A1 (en) * | 2002-02-26 | 2004-07-08 | Grinstaff Mark W. | Novel dendritic polymers and their biomedical uses |
| US7741116B2 (en) | 2002-03-06 | 2010-06-22 | University Of Cincinnati | Surgical device for skin therapy or testing |
| US6905105B2 (en) * | 2002-03-06 | 2005-06-14 | University Of Cincinnati | Apparatus for preparing a biocompatible matrix |
| WO2003092468A2 (en) * | 2002-04-29 | 2003-11-13 | Gel-Del Technologies, Inc. | Biomatrix structural containment and fixation systems and methods of use thereof |
| AU2003276926B2 (en) * | 2002-09-18 | 2009-02-05 | Warsaw Orthopedic, Inc. | Natural tissue devices and methods of implantation |
| US7744651B2 (en) * | 2002-09-18 | 2010-06-29 | Warsaw Orthopedic, Inc | Compositions and methods for treating intervertebral discs with collagen-based materials |
| US7309359B2 (en) * | 2003-08-21 | 2007-12-18 | Warsaw Orthopedic, Inc. | Allogenic/xenogenic implants and methods for augmenting or repairing intervertebral discs |
| US20040054414A1 (en) * | 2002-09-18 | 2004-03-18 | Trieu Hai H. | Collagen-based materials and methods for augmenting intervertebral discs |
| JP2006515765A (ja) * | 2002-11-15 | 2006-06-08 | エスディージーアイ・ホールディングス・インコーポレーテッド | 滑膜性関節を治療するためのコラーゲンベース材料および方法 |
| FR2847269B1 (fr) * | 2002-11-19 | 2006-07-28 | Coletica | Procede d'identification d'une modification eventuelle d'au moins un parametre biologique mettant en oeuvre des cellules vivantes jeunes et agees |
| US20040186471A1 (en) * | 2002-12-07 | 2004-09-23 | Sdgi Holdings, Inc. | Method and apparatus for intervertebral disc expansion |
| US7468050B1 (en) | 2002-12-27 | 2008-12-23 | L. Vad Technology, Inc. | Long term ambulatory intra-aortic balloon pump |
| CA2531099A1 (en) * | 2003-04-10 | 2004-10-28 | Light Bioscience, Llc | Photomodulation methods and devices for regulating cell proliferation and gene expression |
| US7067123B2 (en) * | 2003-04-29 | 2006-06-27 | Musculoskeletal Transplant Foundation | Glue for cartilage repair |
| US8034048B2 (en) | 2003-05-05 | 2011-10-11 | Boston Scientific Scimed, Inc. | Tissue patches and related delivery systems and methods |
| US7416546B2 (en) * | 2003-05-05 | 2008-08-26 | Boston Scientific Scimed, Inc. | Tissue patches and related delivery systems and methods |
| US7901457B2 (en) | 2003-05-16 | 2011-03-08 | Musculoskeletal Transplant Foundation | Cartilage allograft plug |
| US8465537B2 (en) * | 2003-06-17 | 2013-06-18 | Gel-Del Technologies, Inc. | Encapsulated or coated stent systems |
| JP4739202B2 (ja) * | 2003-07-31 | 2011-08-03 | ジェントルウェイブス エルエルシー | 熱傷、創傷、および関連皮膚疾患の光力学治療のためのシステムおよび方法 |
| US8153591B2 (en) * | 2003-08-26 | 2012-04-10 | Gel-Del Technologies, Inc. | Protein biomaterials and biocoacervates and methods of making and using thereof |
| WO2005089039A2 (en) | 2004-02-06 | 2005-09-29 | Daniel Barolet | Method and device for the treatment of mammalian tissues |
| JP4563449B2 (ja) * | 2004-03-26 | 2010-10-13 | ヌヴァシヴ インコーポレイテッド | 人工脊椎円板 |
| US7597885B2 (en) * | 2004-03-26 | 2009-10-06 | Aderans Research Institute, Inc. | Tissue engineered biomimetic hair follicle graft |
| JP2007530120A (ja) * | 2004-03-26 | 2007-11-01 | ヌヴァシヴ インコーポレイテッド | 脊椎円板髄核置換用多孔質インプラント |
| US20080269900A1 (en) * | 2004-05-20 | 2008-10-30 | Christopher Reah | Surgical Implants |
| WO2005115259A2 (en) * | 2004-05-24 | 2005-12-08 | Biomedical Strategies | Wound closure system and methods |
| AR050212A1 (es) * | 2004-08-13 | 2006-10-04 | Aderans Res Inst Inc | Organogenesis a partir de celulas disociadas |
| US20060058238A1 (en) * | 2004-09-15 | 2006-03-16 | Lee Laurent-Applegate | Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same |
| US7837740B2 (en) | 2007-01-24 | 2010-11-23 | Musculoskeletal Transplant Foundation | Two piece cancellous construct for cartilage repair |
| JP5138384B2 (ja) * | 2005-01-10 | 2013-02-06 | サイトリ セラピューティクス インコーポレイテッド | 医療装置を監視し、管理し、サービスするための装置及び方法 |
| US7759120B2 (en) * | 2005-03-02 | 2010-07-20 | Kps Bay Medical, Inc. | Seeding implantable medical devices with cells |
| US20060199265A1 (en) * | 2005-03-02 | 2006-09-07 | Wolf Michael F | Seeding implantable medical devices with cells |
| EP1895946A4 (en) * | 2005-06-03 | 2012-11-21 | Nuvasive Inc | IMPROVEMENTS FROM AND RELATED TO SURGICAL IMPLANTS |
| GB0514891D0 (en) * | 2005-07-20 | 2005-08-24 | Pearsalls Ltd | Improvements in and relating to implants |
| US7815926B2 (en) | 2005-07-11 | 2010-10-19 | Musculoskeletal Transplant Foundation | Implant for articular cartilage repair |
| CA2623106C (en) | 2005-09-19 | 2013-12-24 | Histogenics Corporation | Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof |
| AU2006304277B2 (en) | 2005-10-13 | 2012-07-05 | Celularity Inc. | Immunomodulation using placental stem cells |
| AR057158A1 (es) * | 2005-10-17 | 2007-11-21 | Aderans Res Inst Inc | Metodo de administracion de celulas a la piel |
| AR057628A1 (es) * | 2005-11-22 | 2007-12-05 | Aderans Res Inst Inc | Injertos capilares derivados de cabello extirpado |
| TW200800240A (en) * | 2005-11-22 | 2008-01-01 | Aderans Res Inst Inc | Hair follicle graft from tissue engineered skin |
| US20090306776A1 (en) | 2006-01-25 | 2009-12-10 | Children's Medical Center Corporation | Methods and procedures for ligament repair |
| CN101421002B (zh) * | 2006-02-09 | 2012-09-26 | 阿德兰斯研究学院有限公司 | 用于将流体和材料输送到对象中的装置和方法 |
| WO2007139551A1 (en) * | 2006-05-30 | 2007-12-06 | Cytori Therapeutics, Inc. | Systems and methods for manipulation of regenerative cells from adipose tissue |
| CN101501185A (zh) * | 2006-06-09 | 2009-08-05 | 人类起源公司 | 胎盘巢(placental niche)及其培养干细胞的用途 |
| US8399619B2 (en) | 2006-06-30 | 2013-03-19 | Warsaw Orthopedic, Inc. | Injectable collagen material |
| US8118779B2 (en) | 2006-06-30 | 2012-02-21 | Warsaw Orthopedic, Inc. | Collagen delivery device |
| US20100015104A1 (en) * | 2006-07-26 | 2010-01-21 | Cytori Therapeutics, Inc | Generation of adipose tissue and adipocytes |
| WO2008060361A2 (en) | 2006-09-28 | 2008-05-22 | Children's Medical Center Corporation | Methods and collagen products for tissue repair |
| US7942104B2 (en) * | 2007-01-22 | 2011-05-17 | Nuvasive, Inc. | 3-dimensional embroidery structures via tension shaping |
| US7946236B2 (en) * | 2007-01-31 | 2011-05-24 | Nuvasive, Inc. | Using zigzags to create three-dimensional embroidered structures |
| USD606190S1 (en) | 2007-02-08 | 2009-12-15 | Aderans Research Institute, Inc. | Device for delivering cellular material and physiologic fluids to a subject |
| WO2008098125A2 (en) * | 2007-02-08 | 2008-08-14 | Nuvasive, Inc. | Medical implants with pre-settled cores and related methods |
| EP2687220A3 (en) | 2007-02-12 | 2014-05-14 | Anthrogenesis Corporation | Treatment of inflammatory diseases using placental stem cells |
| US8435551B2 (en) | 2007-03-06 | 2013-05-07 | Musculoskeletal Transplant Foundation | Cancellous construct with support ring for repair of osteochondral defects |
| US7632340B2 (en) * | 2007-03-07 | 2009-12-15 | Hamilton Beach Brands, Inc. | Air purifier for removing particles or contaminants from air |
| WO2008112170A1 (en) * | 2007-03-09 | 2008-09-18 | Corning Incorporated | Three dimensional gum matrices for cell culture, manufacturing methods and methods of use |
| US20080220526A1 (en) * | 2007-03-09 | 2008-09-11 | Ellison Adam J | Gum coatings for cell culture, methods of manufacture and methods of use |
| AU2008262333B2 (en) * | 2007-06-08 | 2014-07-17 | Wake Forest University Health Sciences | Selective cell therapy for the treatment of renal failure |
| US9580688B2 (en) * | 2007-06-08 | 2017-02-28 | Wake Forest University Health Sciences | Kidney structures and methods of forming the same |
| US7985537B2 (en) * | 2007-06-12 | 2011-07-26 | Aderans Research Institute, Inc. | Methods for determining the hair follicle inductive properties of a composition |
| US20090004253A1 (en) * | 2007-06-29 | 2009-01-01 | Brown Laura J | Composite device for the repair or regeneration of tissue |
| US8282681B2 (en) * | 2007-08-13 | 2012-10-09 | Nuvasive, Inc. | Bioresorbable spinal implant and related methods |
| AU2008345047A1 (en) * | 2007-12-26 | 2009-07-09 | Gel-Del Technologies, Inc. | Biocompatible protein particles, particle devices and methods thereof |
| WO2009111069A1 (en) * | 2008-03-05 | 2009-09-11 | Musculoskeletal Transplant Foundation | Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles |
| US8377135B1 (en) | 2008-03-31 | 2013-02-19 | Nuvasive, Inc. | Textile-based surgical implant and related methods |
| JP5882733B2 (ja) | 2008-04-01 | 2016-03-09 | ザ ジェネラル ホスピタル コーポレイション | 組織移植の方法と装置 |
| WO2010021993A1 (en) | 2008-08-19 | 2010-02-25 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease |
| WO2010057013A1 (en) * | 2008-11-14 | 2010-05-20 | Wake Forest University Health Sciences | Selective cell therapy for the treatment of renal failure |
| WO2010057177A2 (en) | 2008-11-17 | 2010-05-20 | Gel-Del Technologies, Inc. | Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof |
| US20100274362A1 (en) * | 2009-01-15 | 2010-10-28 | Avner Yayon | Cartilage particle tissue mixtures optionally combined with a cancellous construct |
| KR101738324B1 (ko) * | 2009-05-01 | 2017-05-19 | 비미니 테크놀로지스 엘엘씨 | 조직 및 세포 부유화 이식편의 최적화 시스템, 방법 및 조성물 |
| WO2011025866A1 (en) * | 2009-08-28 | 2011-03-03 | Innovative Health Technologies, Llc | Polymer adhesive film for directed cellular growth |
| WO2011098367A2 (en) | 2010-02-12 | 2011-08-18 | Universität Zürich | Method for in-vitro production of tissue engineered auto- and allografts suitable for guarded cryopreservation |
| WO2011140497A2 (en) * | 2010-05-07 | 2011-11-10 | The General Hospital Corporation | Method and apparatus for tissue grafting and copying |
| CN102946915B (zh) | 2010-05-25 | 2015-12-09 | 库克生物技术股份有限公司 | 用于医疗移植物的细胞接种的方法、基底和系统 |
| AR093183A1 (es) | 2010-12-31 | 2015-05-27 | Anthrogenesis Corp | Aumento de la potencia de celulas madre de placenta usando moleculas de arn moduladoras |
| AU2012262273B2 (en) | 2011-06-01 | 2017-09-14 | Celularity Inc. | Treatment of pain using placental stem cells |
| US11484578B2 (en) | 2012-02-01 | 2022-11-01 | Children's Medical Center Corporation | Biomaterial for articular cartilage maintenance and treatment of arthritis |
| USD690004S1 (en) | 2012-03-16 | 2013-09-17 | Aderans Research Institute, Inc. | Holder for a device for delivering cellular material and physiologic fluids |
| US9757495B2 (en) | 2013-02-01 | 2017-09-12 | Children's Medical Center Corporation | Collagen scaffolds |
| BR112015019440A8 (pt) | 2013-02-20 | 2019-11-12 | Cytrellis Biosystems Inc | curativo regulável, kit, uso e método para fortalecimento da pele |
| AU2013205148B2 (en) | 2013-03-14 | 2014-10-30 | AVITA Medical Americas, LLC | Systems and methods for tissue processing and preparation of cell suspension therefrom |
| US9993577B2 (en) | 2013-07-01 | 2018-06-12 | Trustees Of Boston University | Dissolvable hydrogel compositions for wound management and methods of use |
| KR20220010055A (ko) | 2013-08-09 | 2022-01-25 | 사이트렐리스 바이오시스템즈, 인크. | 비-열적 조직 절제를 사용한 피부 치료를 위한 방법 및 기구 |
| EP3082897A4 (en) | 2013-12-19 | 2017-07-26 | Cytrellis Biosystems, Inc. | Methods and devices for manipulating subdermal fat |
| JP2017533774A (ja) | 2014-11-14 | 2017-11-16 | サイトレリス バイオシステムズ，インコーポレーテッド | 皮膚のアブレーションのためのデバイス及び方法 |
| US10077420B2 (en) | 2014-12-02 | 2018-09-18 | Histogenics Corporation | Cell and tissue culture container |
| US10070886B2 (en) | 2015-04-22 | 2018-09-11 | Medline Industries, Inc. | Method of harvesting tissue using sequential sections of a two dimensional array of needles |
| AU2017245174A1 (en) | 2016-03-29 | 2018-10-04 | Cytrellis Biosystems, Inc. | Devices and methods for cosmetic skin resurfacing |
| EP4649899A2 (en) | 2016-07-06 | 2025-11-19 | Children's Medical Center Corporation | Indirect method of articular tissue repair |
| BR112019005312A2 (pt) | 2016-09-21 | 2019-07-16 | Cytrellis Biosystems Inc | dispositivos e métodos para a recomposição cosmética da pele |
| DE202023002795U1 (de) | 2022-12-27 | 2024-07-15 | AVITA Medical Americas, LLC | System zur automatisierten Herstellung einer regenerativen epidermalen Suspension |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5237896A (en) * | 1975-09-17 | 1977-03-24 | Toray Industries | Multiifilament yarn for water jet loom and fabric weaving method |
| JPS55501130A (enExample) * | 1978-12-26 | 1980-12-18 | ||
| JPS58501772A (ja) * | 1981-10-26 | 1983-10-20 | マサチユ−セツツ・インステチユ−ト・オブ・テクノロジ− | 遠心による繊維格子中への細胞の接種方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3955012A (en) * | 1970-08-06 | 1976-05-04 | Zaidan Hojin, Seisan Kaihatsu Kagaku Kenkyusho | Method for manufacturing medical articles composed of silicone rubber coated with collagen |
| US3826678A (en) * | 1972-06-06 | 1974-07-30 | Atomic Energy Commission | Method for preparation of biocompatible and biofunctional materials and product thereof |
| US4280954A (en) * | 1975-07-15 | 1981-07-28 | Massachusetts Institute Of Technology | Crosslinked collagen-mucopolysaccharide composite materials |
| CA1157403A (en) * | 1979-01-02 | 1983-11-22 | Magdalena G. Eisinger | Process for growing human epidermal cells in tissue culture |
| US4352883A (en) * | 1979-03-28 | 1982-10-05 | Damon Corporation | Encapsulation of biological material |
| US4304866A (en) * | 1979-11-14 | 1981-12-08 | Massachusetts Institute Of Technology | Transplantable sheets of living keratinous tissue |
| US4326532A (en) * | 1980-10-06 | 1982-04-27 | Minnesota Mining And Manufacturing Company | Antithrombogenic articles |
-
1981
- 1981-10-26 US US06/315,233 patent/US4458678A/en not_active Expired - Lifetime
-
1982
- 1982-10-26 JP JP82503548A patent/JPS58501817A/ja active Granted
- 1982-10-26 AT AT82903564T patent/ATE20186T1/de active
- 1982-10-26 EP EP82903564A patent/EP0091952B1/en not_active Expired
- 1982-10-26 WO PCT/US1982/001513 patent/WO1983001384A1/en not_active Ceased
- 1982-10-26 DE DE8282903564T patent/DE3271581D1/de not_active Expired
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5237896A (en) * | 1975-09-17 | 1977-03-24 | Toray Industries | Multiifilament yarn for water jet loom and fabric weaving method |
| JPS55501130A (enExample) * | 1978-12-26 | 1980-12-18 | ||
| JPS58501772A (ja) * | 1981-10-26 | 1983-10-20 | マサチユ−セツツ・インステチユ−ト・オブ・テクノロジ− | 遠心による繊維格子中への細胞の接種方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS58501817A (ja) | 1983-10-27 |
| EP0091952A1 (en) | 1983-10-26 |
| US4458678A (en) | 1984-07-10 |
| WO1983001384A1 (en) | 1983-04-28 |
| ATE20186T1 (de) | 1986-06-15 |
| EP0091952B1 (en) | 1986-06-04 |
| DE3271581D1 (en) | 1986-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4505266A (en) | Method of using a fibrous lattice | |
| US4458678A (en) | Cell-seeding procedures involving fibrous lattices | |
| US4418691A (en) | Method of promoting the regeneration of tissue at a wound | |
| US5665391A (en) | Cultured, full-thickness integument substitutes based on three-dimensional matrix membranes | |
| Coulomb et al. | Advantage of the presence of living dermal fibroblasts within in vitro reconstructed skin for grafting in humans | |
| US9089417B2 (en) | Surgical device for skin therapy or testing | |
| US5716411A (en) | Method of skin regeneration using a collagen-glycosaminoglycan matrix and cultured epithelial autograft | |
| KR100195574B1 (ko) | 생체 적합성 천공막 및 이의 제조방법 | |
| JP6469655B2 (ja) | 代用皮膚および毛包新生の方法 | |
| JPH0747043B2 (ja) | 合成生体皮膚等価物 | |
| Beele | Artificial skin: past, present and future | |
| JP2002504412A (ja) | 生きたキメラ皮膚置換体 | |
| DE10041468C1 (de) | Hautmatrix zur Abdeckung und Regenerierung verletzter Hautpartien sowie Verfahren zu ihrer Herstellung | |
| Atnip et al. | Skin coverage | |
| CA1205382A (en) | Cell-seeding procedures involving fibrous lattices | |
| CA1202898A (en) | Cell-seeding into fibrous lattices by means of centrifugation | |
| Cevher et al. | Bioengineered wound and burn healing substitutes: novel design for biomedical applications and general aspects. | |
| Kinner et al. | Skin transplantation | |
| Lommen | Artificial skin | |
| WO1998013076A1 (en) | Cultured cell-seeded fibrous lattice for tissue replacement | |
| Moy et al. | 7.10 Burn Dressings | |
| HK1156073B (en) | A method of producing a cultured skin device |